Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982–3021.

Article  PubMed  PubMed Central  Google Scholar 

Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24(11):987–1003.

Article  CAS  PubMed  Google Scholar 

SCORE2 risk prediction algorithms. new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021;42(25):2439–54.

Article  Google Scholar 

Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A, et al. ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH). J Hypertens. 2023 Jun 21. https://doi.org/10.1097/HJH.0000000000003480. Online ahead of print.

Staplin N, de la Sierra A, Ruilope LM, Emberson JR, Vinyoles E, Gorostidi M, et al. Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59 124 patients. Lancet 2023 Jun 17;401(10393):2041-2050.

Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38(32):2459–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143-421.

Nakamura M, Kayamori Y, Iso H, Kitamura A, Kiyama M, Koyama I, et al. LDL cholesterol performance of beta quantification reference measurement procedure. Clin Chim Acta. 2014;431:288–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.

Article  CAS  PubMed  Google Scholar 

Sajja A, Park J, Sathiyakumar V, Varghese B, Pallazola VA, Marvel FA, et al. Comparison of methods to estimate low-density lipoprotein cholesterol in patients with high triglyceride levels. JAMA Netw Open. 2021;4(10): e2128817.

Article  PubMed  PubMed Central  Google Scholar 

Bolat S, Ertürk Zararsız G, Doğan K, Kochan N, Yerlitaş SI, Cephe A, et al. Concordance of LDL-C estimating equations with direct enzymatic measurement in diabetic and prediabetic subjects. J Clin Med . 2023 May 20;12(10):3570. https://doi.org/10.3390/jcm12103570.

Martin SS, Blaha MJ, Elshazly MB, Toth PP, Kwiterovich PO, Blumenthal RS, et al. Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile. JAMA. 2013;310(19):2061–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martin SS, Giugliano RP, Murphy SA, Wasserman SM, Stein EA, Ceška R, et al. Comparison of low-density lipoprotein cholesterol assessment by martin/hopkins estimation, friedewald estimation, and preparative ultracentrifugation: insights from the FOURIER Trial. JAMA Cardiol. 2018;3(8):749–53.

Article  PubMed  PubMed Central  Google Scholar 

Sampson M, Ling C, Sun Q, Harb R, Ashmaig M, Warnick R, et al. A new equation for calculation of low-density lipoprotein cholesterol in patients with normolipidemia and/or hypertriglyceridemia. JAMA Cardiol. 2020;5(5):540–8.

Article  PubMed  Google Scholar 

Ginsberg HN, Rosenson RS, Hovingh GK, Letierce A, Samuel R, Poulouin Y, et al. LDL-C calculated by Friedewald, Martin-Hopkins, or NIH equation 2 versus beta-quantification: pooled alirocumab trials. J Lipid Res . 2022 Jan;63(1):100148. https://doi.org/10.1016/j.jlr.2021.100148. Epub 2021 Nov 11.

Briers PJ, Langlois MR. Concordance of apolipoprotein B concentration with the Friedewald, Martin-Hopkins, and Sampson formulas for calculating LDL cholesterol. Biochem Med (Zagreb). 2022;32(1): 010704.

PubMed  Google Scholar 

Giulietti F, Filipponi A, Rosettani G, Giordano P, Iacoacci C, Spannella F, et al. Pharmacological approach to smoking cessation: an updated review for daily clinical practice. High Blood Press Cardiovasc Prev. 2020;27(5):349–62.

Article  PubMed  PubMed Central  Google Scholar 

Omboni S, Palatini P, Parati G. Standards for ambulatory blood pressure monitoring clinical reporting in daily practice: recommendations from the Italian Society of Hypertension. Blood Press Monit. 2015;20(5):241–4.

Article  PubMed  Google Scholar 

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104.

Article  PubMed  Google Scholar 

Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J. 2019;41(1):111–88.

Article  Google Scholar 

Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227–337.

Article  PubMed  Google Scholar 

Stergiou GS, Palatini P, Parati G, O’Brien E, Januszewicz A, Lurbe E, et al. 2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement. J Hypertens. 2021;39(7):1293–302.

Article  CAS  PubMed  Google Scholar 

Volpe M, Gallo G, Modena MG, Ferri C, Desideri G, Tocci G. Updated recommendations on cardiovascular prevention in 2022: an executive document of the italian society of cardiovascular prevention. High Blood Press Cardiovasc Prev. 2022;29(2):91–102.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boskovic N, Giga V, Djordjevic-Dikic A, Beleslin B, Stojkovic S, Nedeljkovic I, et al. Comparison of SCORE and SCORE 2 risk prediction tools in contemporary very high risk european population. European Heart Journal, Volume 43, Issue Supplement_2, October 2022, ehac544.2281, https://doi.org/10.1093/eurheartj/ehac544.2281

Csenteri O, Jancsó Z, Szöllösi GJ, Andréka P, Vajer P. Differences of cardiovascular risk assessment in clinical practice using SCORE and SCORE2. Open Heart . 2022 Nov;9(2):e002087. https://doi.org/10.1136/openhrt-2022-002087.

Del Pinto R, Giua C, Keber E, Grippa E, Tilotta M, Ferri C. Impact of 2021 ESC Guidelines for cardiovascular disease prevention on hypertensive patients risk: secondary analysis of save your heart study. High Blood Press Cardiovasc Prev. 2023;30(2):167–73.

Article  PubMed  PubMed Central  Google Scholar 

Spannella F, Giulietti F, Di Pentima C, Sarzani R. Prevalence and control of dyslipidemia in patients referred for high blood pressure: the disregarded “Double-Trouble” lipid profile in overweight/obese. Adv Ther. 2019;36(6):1426–37.

Article  PubMed  PubMed Central  Google Scholar 

Borghi C, Fogacci F, Agnoletti D, Cicero AFG. Hypertension and dyslipidemia combined therapeutic approaches. High Blood Press Cardiovasc Prev. 2022;29(3):221–30.

Article  PubMed  PubMed Central  Google Scholar 

Sarzani R, Laureti G, Gezzi A, Spannella F, Giulietti F. Single-pill fixed-dose drug combinations to reduce blood pressure: the right pill for the right patient. Ther Adv Chronic Dis. 2022;13:20406223221102750.

Article  PubMed  PubMed Central  Google Scholar 

Martins J, Steyn N, Rossouw HM, Pillay TS. Best practice for LDL-cholesterol: when and how to calculate. J Clin Pathol. 2023;76(3):145–52.

Article  CAS  PubMed  Google Scholar 

Mortensen MB, Nordestgaard BG. Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70–100 years: a contemporary primary prevention cohort. Lancet. 2020;396(10263):1644–52.

Article  CAS  PubMed  Google Scholar 

Gencer B, Marston NA, Im K, Cannon CP, Sever P, Keech A, et al. Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials. Lancet. 2020;396(10263):1637–43.

Article  CAS  PubMed  PubMed Central  Google Scholar